Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC for Pancreatic Cancer with Peritoneal Metastasis
NCT04858009Phase 2Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Feb 2024
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in pancreatic cancer (PC), sponsored by Mayo Clinic. Started Feb 2024; status: active, not recruiting.
02
Drugs
paclitaxelcisplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04858009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858009.